Pharmacological actions of statins: a critical appraisal in the management of cancer
P Gazzerro, MC Proto, G Gangemi, AM Malfitano… - Pharmacological …, 2012 - ASPET
Statins, among the most commonly prescribed drugs worldwide, are cholesterol-lowering
agents used to manage and prevent cardiovascular and coronary heart diseases. Recently …
agents used to manage and prevent cardiovascular and coronary heart diseases. Recently …
Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis
MR Law, NJ Wald, AR Rudnicka - Bmj, 2003 - bmj.com
Objectives To determine by how much statins reduce serum concentrations of low density
lipoprotein (LDL) cholesterol and incidence of ischaemic heart disease (IHD) events and …
lipoprotein (LDL) cholesterol and incidence of ischaemic heart disease (IHD) events and …
Dosing time matters
Physicians diagnose and administer treatment as needed; time of day is rarely considered.
Yet, accumulating evidence shows that our molecular clocks orchestrate 24-hour circadian …
Yet, accumulating evidence shows that our molecular clocks orchestrate 24-hour circadian …
Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update
M Schachter - Fundamental & clinical pharmacology, 2005 - Wiley Online Library
Statins are the treatment of choice for the management of hypercholesterolaemia because of
their proven efficacy and safety profile. They also have an increasing role in managing …
their proven efficacy and safety profile. They also have an increasing role in managing …
Clinical pharmacokinetics of atorvastatin
H Lennernäs - Clinical pharmacokinetics, 2003 - Springer
Hypercholesterolaemia is a risk factor for the development of atherosclerotic disease.
Atorvastatin lowers plasma low-density lipoprotein (LDL) cholesterol levels by inhibition of …
Atorvastatin lowers plasma low-density lipoprotein (LDL) cholesterol levels by inhibition of …
Atorvastatin: a review of its pharmacology and therapeutic potential in the management of hyperlipidaemias
AP Lea, D McTavish - Drugs, 1997 - Springer
Synopsis Atorvastatin is a synthetic HMG-CoA reductase inhibitor which lowers plasma
cholesterol levels by inhibiting endogenous cholesterol synthesis. It also reduces …
cholesterol levels by inhibiting endogenous cholesterol synthesis. It also reduces …
Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial
L Papazian, A Roch, PE Charles, C Penot-Ragon… - Jama, 2013 - jamanetwork.com
Importance Observational studies have reported that statin use may be associated with
improved outcomes of various infections. Ventilator-associated pneumonia (VAP) is the most …
improved outcomes of various infections. Ventilator-associated pneumonia (VAP) is the most …
Statins for the prevention and treatment of infections: a systematic review and meta-analysis
IM Tleyjeh, T Kashour, FA Hakim… - Archives of internal …, 2009 - jamanetwork.com
Background Emerging epidemiological evidence suggests that statin use may reduce the
risk of infections and infection-related complications. Our objective was to examine the …
risk of infections and infection-related complications. Our objective was to examine the …
Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studies
HE Bays, PB Moore, MA Drehobl, S Rosenblatt… - Clinical …, 2001 - Elsevier
Background: Ezetimibe (SCH 58235) is a novel cholesterol absorption inhibitor that
selectively and potently blocks intestinal absorption of dietary and biliary cholesterol …
selectively and potently blocks intestinal absorption of dietary and biliary cholesterol …
Circadian clock regulation on lipid metabolism and metabolic diseases
X Pan, S Mota, B Zhang - Lipid Transfer in Lipoprotein Metabolism and …, 2020 - Springer
The basic helix-loop-helix-PAS transcription factor (CLOCK, Circadian locomotor output
cycles protein kaput) was discovered in 1994 as a circadian clock. Soon after its discovery …
cycles protein kaput) was discovered in 1994 as a circadian clock. Soon after its discovery …